BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

China's Guangzhou hosts Golden Age Single-Cell and Spatial Omics Conference

The conference brings together on site over 2,000 professionals from academia, research and development, investment and other fields interested to the conf...

May 09, 2023 | News

Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody

HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...

May 09, 2023 | News

Neuro3 Therapeutics obtains global rights for KCNQ2 activators from Lundbeck

The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...

May 09, 2023 | Opinion

Singapore Approves New Therapy for Rare Gastrointestinal Stromal Tumors

Singapore's Health Sciences Authority (HSA) has approved QINLOCK® (ripretinib) for the treatment of patients with 4th line GIST QINLO...

May 08, 2023 | News

Cambridge Infinitus Research Centre Launches AI-based ERnet Platform for Cellular Health Studies.

With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...

May 05, 2023 | News

ABM Initiates Phase I Clinical Trial of MEK Inhibitor for Solid Tumor, Doses First Patient

MEK (mitogen-activated protein kinase kinase), a key kinase of the MAPK pathway, is frequently activated in various cancers, including those with RAS mutat...

May 05, 2023 | News

SHL Medical and MoonLake Immunotherapeutics Partner to Develop Sonelokimab Autoinjector.

Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...

May 04, 2023 | News

The Impact of Digital Health Technologies in Oncology: Current State and Future Directions

Digital health has revolutionized the way healthcare is delivered and managed in recent years. Oncology is one field that has benefited significantly from ...

May 03, 2023 | Opinion

Cellenkos Doses First Patient with CK0803 Cell Therapy for ALS Treatment

Cellenkos® Inc., a clinical stage biotechnology company focused on developing allogeneic, off-the-shelf, T regulatory cell therapies for treatment...

May 03, 2023 | News

Merck to Establish BioProcessing Production Center in South Korea with Ministry and Daejeon City

MoU with Merck's Life Science business aimed at supporting the region's healthcare ecosystem Proposed bioprocessing facility to be based in Daej...

May 03, 2023 | News

MicrofluidX and Immatics working together on automated end-to-end bioprocessing for TCR-T therapies

MicrofluidX, a UK-based provider of next generation bioreactors for cell biology research and cell therapy manufacturing, today announces a joint research ...

May 03, 2023 | News

Astellas Enters Into Definitive Agreement to Acquire Iveric Bio

-Lead Program, Avacincaptad Pegol for the Potential Treatment of Geographic Atrophy with PDUFA Goal Date of August 19, 2023- -Acquisition advances A...

May 01, 2023 | News

Gilead Sciences Announces Launch of Asia Pacific Rainbow Grant 2023

–Gilead Sciences Celebrates the Fifth Anniversary Milestone of the Asia Pacific Rainbow Grant, with More Than US$4.5 Million Awarded to Organ...

May 01, 2023 | News

OBiO and CHINAGENE to provide gene therapy commercial manufacturing services under strategic agreement.

"This agreement signed by OBiO and CHINAGENE is a continuation and sublimation from previous cooperation," Guodong Jia, CEO of OBiO said, "CHINAGENE i...

April 30, 2023 | News

Stay Connected